Tissue Microarray Market Performance and Future Outlook at 12.3% CAGR Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the tissue microarray market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Tissue Microarray Industry By 2029?

The tissue microarray market has experienced robust expansion in recent years. This market is projected to increase from $12.05 billion in 2024 to $13.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. Historically, this growth was primarily fueled by the advancement of precision medicine, innovations in drug discovery and development, the demand for efficient analysis, the increasing occurrence of chronic diseases, and various biobanking initiatives.

The tissue microarray market size is anticipated to experience substantial growth over the next few years. Its valuation is set to reach $20.85 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion over the forecast period stems from the emergence of digital pathology, broader applications, the expanding biopharmaceutical sector, regulatory backing and established standards, along with the incorporation of AI and machine learning. Prominent trends expected during this period encompass advancements in imaging technologies, the development of 3D tissue microarrays, high-content screening methods, standardization efforts, and the integration of single-cell analysis.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

What Major Drivers Are Impacting The Tissue Microarray Market?

The increasing incidence of cancer is anticipated to fuel the expansion of the tissue microarray market in the future. Cancer refers to a group of diseases characterized by the uncontrolled proliferation of abnormal cells within any organ or tissue, which then transgress their normal limits and either spread to distant organs or infiltrate adjacent body regions. In oncology, tissue arrays serve to analyze the expression of biomarkers associated with cancer across diverse tumor specimens. For example, data released by Macmillan Cancer Support, a UK-based cancer charity, in June 2022 indicated that the population living with cancer reached 3 million in 2022 within the UK and is forecasted to climb to approximately 3.5 million by 2025 and 4 million by 2030. Consequently, the rising prevalence of cancer cases is stimulating the growth of the tissue microarray market.

Which Segment Categories Are Driving Maximum Growth In The Tissue Microarray Market?

The tissue microarraymarket covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Which Long-Term Trends Will Play A Crucial Role In The Tissue Microarray Market?

A significant development gaining traction within the tissue microarray market involves strategic partnerships. Prominent entities within the tissue microarray sector are engaging in collaborations to cultivate new relationships, leading to the joint advancement of tissue microarray technologies by two or more organizations. For example, in November 2022, The Cureline Group, a US-based CRO specializing in translational and precision medicine, which offers HBS biobanking and laboratory services, collaborated with Cellecta Inc., a US-based supplier of RNAi and CRISPR screening solutions. This partnership resulted in the introduction of Tissue 2 Target Services, a new strategic alliance designed to merge their respective core competencies in the molecular analysis of cells and tissues with human biospecimen management. The objective is to provide pre-clinical and translational research facilities focused on gene target and biomarker discovery services, thus optimizing workflows. Additionally, in September 2022, Ultivue Inc., a US-based biotechnology firm that develops reagent-based solutions to maximize biological information from cells and tissue samples, formed a partnership with ngTMA, a Switzerland-based Translational Research Unit (TRU) platform associated with the University of Bern, which innovates workflows for tissue microarray construction. This alliance intends to advance multiplexed immunofluorescence (mIF) assays and implement new TMA technologies to unlock spatial analysis in scientific research, thereby enhancing the quality of TMAs utilized in clinical and translational studies.

Who Are The Dominant Players In The Tissue Microarray Market Today?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Region Is At The Forefront Of Innovation In The Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795